US Stock MarketDetailed Quotes

ZTS Zoetis

Watchlist
  • 165.020
  • +2.200+1.35%
Close Mar 27 16:00 ET
  • 165.050
  • +0.030+0.02%
Pre 08:24 ET
73.89BMarket Cap30.17P/E (TTM)

About Zoetis Company

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Company Profile

SymbolZTS
Company NameZoetis
Listing DateFeb 1, 2013
Issue Price26.00
Founded1952
CEOMs. Kristin C. Peck
MarketNYSE
Employees13800
Fiscal Year Ends12-31
Address10 Sylvan Way
CityParsippany
ProvinceNew Jersey
CountryUnited States of America
Zip Code07054
Phone1-973-822-7000
Websitehttp://www.zoetis.com

Company Executives

  • Name
  • Position
  • Salary
  • Kristin C. Peck
  • Director and Chief Executive Officer
  • 15.24M
  • Roxanne Lagano
  • Chief Human Resources Officer, Executive Vice President, Global Operations and Interim General Counsel and Corporate Secretary
  • --
  • Julie Fuller
  • Executive Vice President, Global Operations and Chief Human Resources Officer
  • --
  • Jeannette Ferran Astorga
  • Executive Vice President, Corporate Affairs, Communications and Chief Sustainability Officer
  • --
  • Wetteny Joseph
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 4.25M
  • Keith Sarbaugh
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer
  • --
  • Jamie Brannan
  • Executive Vice President and Chief Commercial Officer
  • --
  • Rimma Driscoll
  • Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
  • --
  • Nick Ashton
  • Executive Vice President and President, Global Manufacturing and Supply
  • --
  • Dr. Robert J. Polzer, PhD
  • Executive Vice President and President, Research and Development
  • 2.44M
  • Jared Shriver
  • President, U.S. Operations
  • --
  • Michael B. McCallister
  • Non-Executive Chairman of the Board
  • 490.00K
  • Gavin D.K. Hattersley
  • Director
  • --
  • Vanessa Broadhurst
  • Independent Director
  • 341.00K
  • Louise M. Parent
  • Independent Director
  • 370.00K
  • Antoinette R. Leatherberry
  • Independent Director
  • 340.00K
  • Sanjay Khosla
  • Independent Director
  • 340.00K
  • Robert W. Scully
  • Independent Director
  • 365.00K
  • Paul M. Bisaro
  • Independent Director
  • 340.00K
  • Gregory Norden
  • Independent Director
  • 365.00K
  • Frank A. D'Amelio
  • Independent Director
  • 340.50K
  • Dr. Willie M. Reed
  • Independent Director
  • 370.00K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Ermenegildo Zegna NV
ZGN
7.760
Hutchmed (China)
HCM
15.260
eBay
EBAY
66.810
4
Enerpac Tool
EPAC
46.220
5
Halozyme Therapeutics
HALO
64.480
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.